Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses-Reference-Cited by-同舟云学术

Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses

Author:

Saba C. F.¹^ORCID,Vickery K. R.²,Clifford C. A.²,Burgess K. E.³,Phillips B.⁴,Vail D. M.⁵,Wright Z. M.⁶,Morges M. A.⁷,Fan T. M.⁸,Thamm D. H.⁹

Affiliation:

1. Department of Small Animal Medicine & Surgery; University of Georgia, College of Veterinary Medicine; Athens Georgia

2. Hope Veterinary Specialists; Malvern Pennsylvania

3. Department of Clinical Sciences; Cummings School of Veterinary Medicine at Tufts University; North Grafton Massachusetts

4. Veterinary Specialty Hospital of San Diego; San Diego California

5. Department of Medical Sciences, School of Veterinary Medicine; University of Wisconsin-Madison; Madison Wisconsin

6. VCA Animal Diagnostic Clinic; Dallas Texas

7. Red Bank Veterinary Hospital, Medical Oncology Department; Tinton Falls New Jersey

8. Department of Veterinary Clinical Medicine; University of Illinois at Urbana-Champaign, College of Veterinary Medicine; Urbana Illinois

9. Colorado State University Flint Animal Cancer Center; Fort Collins Colorado

Publisher

Wiley

Subject

General Veterinary

Link

Reference26 articles.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Novel Treatments for Lymphoma;Veterinary Clinics of North America: Small Animal Practice;2024-05

5. Glucocorticoid Therapy in Oncology;Therapeutic Strategies in Veterinary Oncology;2023-08-23